Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9
Journal article
Chan DKH. et al, (2023), STAR Protocols, 4, 101978 - 101978
APOBEC mutagenesis is a common process in normal human small intestine.
Journal article
Wang Y. et al, (2023), Nat Genet
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
Journal article
Brevini T. et al, (2022), Nature
Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells
Journal article
Robinson PS. et al, (2022), Nature Communications, 13
Mutational landscape of normal epithelial cells in Lynch Syndrome patients
Journal article
Lee BCH. et al, (2022), Nature Communications, 13
An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis
Journal article
Jou E. et al, (2022), Science Immunology, 7
Stage migration – a negative quality indicator in colon cancer management
Journal article
Chan DKH. and Buczacki SJA., (2022), Colorectal Disease, 24, 153 - 154
Primary tumour immune response and lymph node yields in colon cancer.
Journal article
Lal N. et al, (2022), Br J Cancer
Cancer Stem Cells
Chapter
Damavandi MD. et al, (2022), Encyclopedia of Cell Biology: Volume 1-6, Second Edition, 6, 114 - 123
FXR AS A NEW THERAPEUTIC TARGET FOR COVID-19
Conference paper
Brevini T. et al, (2021), HEPATOLOGY, 74, 318A - 318A
FXR ANTAGONISTS AS NEW AGENTS FOR COVID19
Conference paper
Brevini T. et al, (2021), GUT, 70, A4 - A4
Tumour heterogeneity and evolutionary dynamics in colorectal cancer
Journal article
Chan DKH. and Buczacki SJA., (2021), Oncogenesis, 10
Targeting acid ceramidase to improve the radiosensitivity of rectal cancer
Journal article
Clifford R. et al, (2020), Cells
5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation
Journal article
Uribe-Lewis S. et al, (2020), Scientific Reports, 10
An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
Journal article
Darvish-Damavandi M. et al, (2020), Br J Surg
The use of oral antibiotics and mechanical bowel preparation in elective colorectal resection for the reduction of surgical site infection
Journal article
Duff SE. et al, (2020), Colorectal Disease, 22, 364 - 372
Fate plasticity in the intestine: The devil is in the detail.
Journal article
Buczacki S., (2019), World J Gastroenterol, 25, 3116 - 3122
Itraconazole targets cell cycle heterogeneity in colorectal cancer.
Journal article
Buczacki SJA. et al, (2018), J Exp Med, 215, 1891 - 1912
Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition.
Journal article
Popova SA. and Buczacki SJA., (2018), Mol Cell Oncol, 5